|Application ||WB, IHC-P, IHC-F, FC|
|Calculated MW||39336 Da|
|Purification||Purified IgG prepared by affinity chromatography on Protein G.|
|Immunogen||C5aR - peptide: Met1 - Asn31|
|Shelf Life||18 months from date of despatch.|
|Other Names||C5a anaphylatoxin chemotactic receptor 1, C5a anaphylatoxin chemotactic receptor, C5a-R, C5aR, CD88, C5AR1, C5AR, C5R1|
|Target/Specificity||Mouse anti-Human CD88 antibody, clone P12/1 recognizes the C5a receptor (C5aR) CD88, which is predominantly expressed on cells of the myeloid lineage. Clone P12/1 was raised against a synthetic peptide comprising the N-terminal extracellular domain of the C5aR (met1-Asn31).Mouse anti-Human CD88 antibody, clone P12/1 does not inhibit the binding of C5a to its receptor.|
|Preservative & Stabilisers||0.09% Sodium Azide|
|Storage||Store at +4℃ or at -20 ℃.|
|Precautions||Anti-Human CD88 Antibody, clone P12/1 is for research use only and not for use in diagnostic or therapeutic procedures.|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
1. Opperman, M. et al. (1993) Probing the human receptor for C5a anaphylatoxin with site-directed antibodies. Identification of a potential ligand binding site on the NH2-terminal domainJ. Immunol. 151: 3785 - 3794. 2. Opperman, M. et al. (1995) Antibodies from the myeloid panel that react with the C5a receptor and anatagonize C5a biological activity.In: Schlossman, S.F. (ed.) Leucocyte Typing V. O.U.P: 955-956. 3. Werfel, T. et al. (1995) Binding of anti-C5a receptor (C5aR) antibodies to cells of clinically normal human skin. In: Schlossman, S.F. (ed.) Leucocyte Typing V. O.U.P.: 957-959. 4. Oppermann, M. (1995) Cluster report: (C5a receptor). In: Schlossman, S.F. (ed.) Leucocyte Typing V. O.U.P. 953-954. 5. Oppermann, M. and Götze, O. (1994) Plasma clearance of the human C5a anaphylatoxin by binding to leucocyte C5a receptorsImmunology. 82: 516-521. 6. Werfel, T. et al. (1996) CD88 antibodies specifically bind to C5aR on dermal CD117+ and CD14+ cells and react with a desmosomal antigen in human skin.J Immunol. 157: 1729-35. 7. Morris, A.C. et al. (2011) C5a-mediated neutrophil dysfunction is RhoA-dependent and predicts infection in critically ill patients.Blood. 117: 5178-88. 8. Hüttenrauch, F. et al. (2005) G protein-coupled receptor kinases promote phosphorylation and beta-arrestin-mediated internalization of CCR5 homo- and hetero-oligomers.J Biol Chem. 280: 37503-15. 9. Nitta, H. et al. (2013) Enhancement of human cancer cell motility and invasiveness by anaphylatoxin C5a via aberrantly expressed C5a receptor (CD88).Clin Cancer Res. 19 (8): 2004-13. 10. Patzelt, J. et al. (2015) Expression of anaphylatoxin receptors on platelets in patients with coronary heart disease.Atherosclerosis. 238 (2): 289-95. 11. Huber-Lang M (2005) Changes in the Novel Orphan, C5a Receptor (C5L2), during Experimental Sepsis and Sepsis in HumansJ Immunol. 174:1104-1110 12. Unnewehr H et al. (2013) Changes and regulation of the C5a receptor on neutrophils during septic shock in humans.J Immunol. 190 (8): 4215-25. 13. Visser T et al. (2011) Isolated blunt chest injury leads to transient activation of circulating neutrophils.Eur J Trauma Emerg Surg. 37 (2): 177-184. 14. Visser T et al. (2012) Homology in systemic neutrophil response induced by human experimental endotoxemia and by trauma.Shock. 37 (2): 145-51. 15. Pollok-Kopp B et al. (2007) Dynamics of protein kinase C-mediated phosphorylation of the complement C5a receptor on serine 334.J Biol Chem. 282 (7): 4345-53.
If you have used an Abgent product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at firstname.lastname@example.org.